|
Variables
|
Group
|
Frequency (n)
|
Percentage (%)
|
|---|
|
(a)
| | | |
|
Age
|
15–24
|
77
|
22.4
|
|
25–34
|
191
|
55.5
|
|
35–44
|
73
|
21.3
|
|
≥ 45
|
3
|
0.9
|
|
Drug resistance (n = 324)
|
No
|
272
|
84.0
|
|
Yes
|
52
|
16.0
|
|
B-lactam
|
20
|
38.5
|
|
MDR
|
17
|
32.7
|
|
Quinolones
|
15
|
28.8
|
|
Mode of delivery
|
Vaginal delivery
|
245
|
71.2
|
|
C-section
|
99
|
28.7
|
|
Mother comorbidities
|
No
|
198
|
56.9
|
|
Yes
|
146
|
42.4
|
|
Maternal complications
|
Abortions
|
205
|
29.8
|
|
Preterm pregnancies
|
152
|
22.1
|
|
Fetal complications
|
No
|
297
|
86.3
|
|
Yes
|
47
|
13.6
|
|
(b)
|
|
Antimicrobial use per trimester (n = 685)
|
First
|
148
|
21.6
|
|
Second
|
212
|
30.9
|
|
Third
|
325
|
47.4
|
|
FDA category for safety drug use during pregnancy
|
Category A
|
0
|
0
|
|
Category B
|
457
|
66.4
|
|
Category C
|
224
|
32.6
|
|
Category D
|
7
|
1.0
|
|
Category X
|
0
|
0
|
|
Allergy
|
No
|
633
|
92.0
|
|
Yes
|
55
|
8.0
|
|
B-lactam
|
12
|
21.8
|
|
Dopaminergic
|
11
|
20.0
|
|
Quinolones
|
7
|
12.7
|
|
NSAIDs
|
6
|
10.9
|
|
Food allergy
|
6
|
10.9
|
|
Danozol
|
3
|
5.5
|
|
Multi drug allergy
|
3
|
5.5
|
|
Corticosteroids
|
2
|
3.6
|
|
Tetracycline
|
2
|
3.6
|
|
Miscellaneous
|
2
|
3.6
|
|
Sulfa drug
|
1
|
1.8
|
|
Indication of antibiotic use
|
Treatment
|
681
|
99.0
|
|
Prophylaxis
|
7
|
1.0
|
